Terms: = Skin cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Treatment
504 results:
1. Curcumin Alone and Combined With pi3k Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
2. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
3. Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
4. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract] [Full Text] [Related]
5. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
6. Simultaneous inhibition of pi3k and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract] [Full Text] [Related]
7. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/pi3k/AKT signaling pathway.
Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
[TBL] [Abstract] [Full Text] [Related]
8. Circular RNA circFCHO2(hsa_circ_0002490) promotes the proliferation of melanoma by directly binding to DND1.
Yang Y; Li J; Wei C; Wang L; Gao Z; Shen K; Li Y; Ren M; Zhu Y; Ding Y; Wei C; Zhang T; Zheng S; Lu N; Gu J
Cell Biol Toxicol; 2024 Feb; 40(1):9. PubMed ID: 38311675
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
10. ATF5 promotes malignant T cell survival through the pi3k/AKT/mTOR pathway in cutaneous T cell lymphoma.
Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
[TBL] [Abstract] [Full Text] [Related]
11. A combined opposite targeting of p110δ pi3k and RhoA abrogates skin cancer.
Tzenaki N; Xenou L; Goulielmaki E; Tsapara A; Voudouri I; Antoniou A; Valianatos G; Tzardi M; De Bree E; Berdiaki A; Makrigiannakis A; Papakonstanti EA
Commun Biol; 2024 Jan; 7(1):26. PubMed ID: 38182748
[TBL] [Abstract] [Full Text] [Related]
12. FBXO3 stabilizes USP4 and Twist1 to promote pi3k-mediated breast cancer metastasis.
Xu J; Guo R; Wen N; Li L; Yi Y; Chen J; He Z; Yang J; Xiao ZJ; Niu M
PLoS Biol; 2023 Dec; 21(12):e3002446. PubMed ID: 38134227
[TBL] [Abstract] [Full Text] [Related]
13. Paris polyphylla saponins II inhibits invasive, migration and epithelial-mesenchymal transition of melanoma cells through activation of autophagy.
Cheng H; Chu J; Yang Y; Li Y; Wang M; Wu H; Wang M; Su J; Li Q
Toxicon; 2024 Jan; 237():107558. PubMed ID: 38072315
[TBL] [Abstract] [Full Text] [Related]
14. Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro.
Yan C; Zhao L; Zhang X; Chu Z; Zhou T; Zhang Y; Geng S; Guo K
J Biophotonics; 2024 Mar; 17(3):e202300356. PubMed ID: 38041219
[TBL] [Abstract] [Full Text] [Related]
15. Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities.
Deng YQ; Gao M; Lu D; Liu QP; Zhang RJ; Ye J; Zhao J; Feng ZH; Li QZ; Zhang H
Phytomedicine; 2024 Jan; 123():155169. PubMed ID: 37992493
[TBL] [Abstract] [Full Text] [Related]
16. MiR126-targeted-nanoparticles combined with pi3k/AKT inhibitor as a new strategy to overcome melanoma resistance.
Arasi MB; De Luca G; Chronopoulou L; Pedini F; Petrucci E; Flego M; Stringaro A; Colone M; Pasquini L; Spada M; Lulli V; Perrotta MC; Calin GA; Palocci C; Biffoni M; Felicetti F; Felli N
Mol Ther; 2024 Jan; 32(1):152-167. PubMed ID: 37990493
[TBL] [Abstract] [Full Text] [Related]
17. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
Guo D; Jurek R; Beaumont KA; Sharp DS; Tan SY; Mariana A; Failes TW; Grootveld AK; Bhattacharyya ND; Phan TG; Arndt GM; Jain R; Weninger W; Tikoo S
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2303978120. PubMed ID: 37963252
[TBL] [Abstract] [Full Text] [Related]
18. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
20. Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.
He Y; Wang X
Comput Biol Med; 2023 Dec; 167():107591. PubMed ID: 37875043
[TBL] [Abstract] [Full Text] [Related]
[Next]